Feline diabetes pill gets FDA green light
December 9, 2022Bexacat has been approval by the U.S. Food and Drug Administration (FDA) for improved glycemic control in diabetic cats. Developed by Elanco Animal Health, the oral medication, which contains the active ingredient bexagliflozin, marks the first sodium-glucose cotransporter 2 (SGLT2) inhibitor (i.e. not insulin) approved by FDA in any animal species, the agency reports.
FDA updates compounding guidelines for vets
December 7, 2022This past summer, the Food and Drug Administration (FDA) issued a new Guidance for Industry (GFI) that will take effect in April 2023, affecting how compounding pharmacies fill veterinary prescriptions. Called GFI #256, the guidance is intended to encourage the use of FDA-approved drugs by veterinary professionals and control which bulk substances are used to create compounded medications.
How the helium crisis impacts vet medicine
December 6, 2022When asked about the challenges facing the veterinary industry, few people will jump straight to a helium shortage. Industrially, helium is primarily used in cryogenics, cooling down machinery to allow proper usage. This includes high-field MRI machines, used throughout the veterinary industry to detect causes of foreign bodies, seizures, spinal pain, and behavioral changes in companion animals. These machines use liquid helium to cool the super-conducting magnet, which creates the strong magnetic field strength required for clarity and consistency while imaging.